Polaris Office Corp. (KOSDAQ:041020)

Ligand Pharmaceuticals Revenue

Polaris Office had revenue of 74.40B KRW in the quarter ending March 31, 2025, with 59.70% growth. This brings the company's revenue in the last twelve months to 304.09B, up 106.41% year-over-year. In the year 2024, Polaris Office had annual revenue of 276.27B with 156.07% growth.

• Revenue (ttm): 304.09B
• Revenue Growth: +106.41%
• P/S Ratio: 0.96
• Revenue / Employee: 2.11B
• Employees: 144
• Market Cap: 291.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	276.27B	168.38B	156.07%
Dec 31, 2023	107.89B	83.71B	346.14%
Dec 31, 2022	24.18B	1.20B	5.23%
Dec 31, 2021	22.98B	3.49B	17.89%
Dec 31, 2020	19.49B	-1.55B	-7.38%